A Phase Ib Study of BKM120 With Weekly Cisplatin and Radiotherapy in High Risk Locally Advanced Squamous Cell Cancer of the Head and Neck
Status: Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 30 Oct 2019
Price : $35 *
At a glance
- Drugs Buparlisib (Primary) ; Cisplatin
- Indications Carcinoma; Head and neck cancer; Hypopharyngeal cancer; Laryngeal cancer; Nasopharyngeal cancer; Oropharyngeal cancer; Squamous cell cancer
- Focus Adverse reactions
- 24 Oct 2019 Planned End Date changed from 1 Mar 2020 to 1 Mar 2021.
- 24 Oct 2019 Planned primary completion date changed from 1 Dec 2019 to 1 Dec 2020.
- 22 Jan 2019 Planned primary completion date changed from 1 Dec 2018 to 1 Dec 2019.